Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts
Catalyst Pharmaceuticals, a commercial-stage biopharmaceutical company focused on rare diseases, has donated $100,000 to the American Red Cross for Hurricane Helene relief efforts. The donation aims to support communities impacted by the widespread devastation caused by the hurricane. Richard J. Daly, President and CEO of Catalyst, expressed the company's commitment to helping those affected during this crisis.
Anne McKeough, Chief Development Officer at the American Red Cross, thanked Catalyst for their generous contribution. The Red Cross has mobilized over 1,400 disaster responders across the Carolinas, Tennessee, Georgia, and Florida to provide shelter, meals, and comfort to families facing destruction. Catalyst's donation will help sustain these vital efforts and bring hope to those in need.
Catalyst Pharmaceuticals, un'azienda biofarmaceutica in fase commerciale focalizzata sulle malattie rare, ha donato 100.000 dollari alla Croce Rossa Americana per gli sforzi di soccorso per l'uragano Helene. La donazione mira a supportare le comunità colpite dalla devastazione diffusa causata dall'uragano. Richard J. Daly, Presidente e CEO di Catalyst, ha espresso l'impegno dell'azienda ad aiutare coloro che sono stati colpiti durante questa crisi.
Anne McKeough, Direttore Sviluppo della Croce Rossa Americana, ha ringraziato Catalyst per la loro generosa contribuzione. La Croce Rossa ha mobilitato oltre 1.400 soccorritori in tutto il Carolina, Tennessee, Georgia e Florida per fornire rifugio, pasti e conforto alle famiglie in difficoltà. La donazione di Catalyst contribuirà a sostenere questi sforzi vitali e a portare speranza a chi ne ha bisogno.
Catalyst Pharmaceuticals, una empresa biofarmacéutica en etapa comercial centrada en enfermedades raras, ha donado 100,000 dólares a la Cruz Roja Americana para los esfuerzos de ayuda por el huracán Helene. La donación tiene como objetivo apoyar a las comunidades afectadas por la devastación generalizada causada por el huracán. Richard J. Daly, Presidente y CEO de Catalyst, expresó el compromiso de la empresa de ayudar a los afectados durante esta crisis.
Anne McKeough, Directora de Desarrollo de la Cruz Roja Americana, agradeció a Catalyst por su generosa contribución. La Cruz Roja ha movilizado a más de 1,400 respondedores de desastres en Carolina del Norte, Tennessee, Georgia y Florida para proporcionar refugio, comidas y consuelo a las familias que enfrentan destrucción. La donación de Catalyst ayudará a sostener estos esfuerzos vitales y traer esperanza a quienes la necesitan.
Catalyst Pharmaceuticals는 희귀 질환에 초점을 맞춘 상업 단계의 생물 의약품 회사로, 10만 달러를 기부했습니다 허리케인 헬렌 구호 활동을 위해 미국 적십자사에. 이 기부는 허리케인으로 인한 광범위한 파괴의 영향을 받은 지역 사회를 지원하는 것을 목표로 하고 있습니다. Richard J. Daly Catalyst의 회장 겸 CEO는 이 위기에 영향을 받은 사람들을 돕겠다는 회사의 약속을 표현했습니다.
미국 적십자사의 개발 책임자인 Anne McKeough는 Catalyst의 관대 한 기부에 감사를 표했습니다. 적십자는 노스캐롤라이나, 테네시, 조지아, 플로리다 전역에서 1,400명 이상의 재난 대응 요원을 동원하여 파괴에 직면한 가족들에게 쉼터, 식사 및 위로를 제공하고 있습니다. Catalyst의 기부는 이러한 중요한 노력을 지속하고 도움이 필요한 사람들에게 희망을 가져다줄 것입니다.
Catalyst Pharmaceuticals, une entreprise biopharmaceutique en phase commerciale axée sur les maladies rares, a doné 100 000 dollars à la Croix-Rouge américaine pour les efforts de secours liés à l'ouragan Helene. La donation vise à soutenir les communautés touchées par la dévastation généralisée causée par l'ouragan. Richard J. Daly, président et PDG de Catalyst, a exprimé l'engagement de l'entreprise à aider ceux qui ont été affectés durant cette crise.
Anne McKeough, directrice du développement à la Croix-Rouge américaine, a remercié Catalyst pour leur généreuse contribution. La Croix-Rouge a mobilisé plus de 1 400 intervenants en cas de catastrophe dans les Carolines, le Tennessee, la Géorgie et la Floride pour fournir abri, repas et réconfort aux familles confrontées à la destruction. La donation de Catalyst aidera à soutenir ces efforts vitaux et à apporter de l'espoir à ceux qui en ont besoin.
Catalyst Pharmaceuticals, ein kommerzielles biopharmazeutisches Unternehmen, das sich auf seltene Krankheiten konzentriert, hat 100.000 Dollar gespendet an das Amerikanische Rote Kreuz für die Hurrikan Helene Hilfsaktionen. Die Spende zielt darauf ab, Gemeinschaften zu unterstützen, die von der weitreichenden Verwüstung durch den Hurrikan betroffen sind. Richard J. Daly, Präsident und CEO von Catalyst, äußerte das Engagement des Unternehmens, den von dieser Krise Betroffenen zu helfen.
Anne McKeough, Chief Development Officer des Amerikanischen Roten Kreuzes, dankte Catalyst für ihren großzügigen Beitrag. Das Rote Kreuz hat über 1.400 Katastropheneinsatzkräfte in den Carolinas, Tennessee, Georgia und Florida mobilisiert, um Schutz, Mahlzeiten und Trost für die von Zerstörung betroffenen Familien bereitzustellen. Die Spende von Catalyst wird dazu beitragen, diese wichtigen Bemühungen aufrechtzuerhalten und Hoffnung für die Bedürftigen zu bringen.
- None.
- None.
CORAL GABLES, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "the Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel therapies for patients with rare diseases, today announced that it has contributed
"At Catalyst, our commitment to the community is unwavering, particularly in times of crisis," said Richard J. Daly, President and CEO of Catalyst. "We extend our heartfelt sympathies to those affected by Hurricane Helene and are honored to contribute to the American Red Cross relief efforts. Through our donation, we aim to help ensure that essential resources reach those who need them most during this challenging time."
“Thanks to Catalyst Pharmaceuticals’ generous donation, the American Red Cross, alongside our partners, is able to support families who experienced the heartbreaking devastation from Hurricane Helene,” said Anne McKeough, Chief Development Officer at the American Red Cross. “We are grateful for partners like Catalyst Pharmaceuticals as we work together to provide comfort and hope to people when they need it most.”
Hurricane Helene has caused widespread devastation, leading to urgent support needs for displaced families. In response to Hurricane Helene, the American Red Cross has mobilized a massive relief effort to bring critical aid to those in need with help. Across the Carolinas, Tennessee, Georgia and Florida, over 1,400 Red Cross disaster responders are working tirelessly to provide safe shelter, meals and comfort to families facing unimaginable destruction. Catalyst's contribution will help sustain these vital efforts and bring hope to those in need.
For those who wish to join in supporting the relief efforts, donations can be made directly to the American Red Cross at https://www.redcross.org.
About Catalyst Pharmaceuticals
Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX) is a biopharmaceutical company committed to improving the lives of patients with rare diseases. With a proven track record of bringing life-changing treatments to the market, we focus on in-licensing, commercializing, and developing innovative therapies. Guided by our deep commitment to patient care, we prioritize accessibility, ensuring patients receive the care they need through a comprehensive suite of support services designed to provide seamless access and ongoing assistance. Catalyst maintains a well-established U.S. presence while actively seeking to expand its global commercial footprint through strategic partnerships. Catalyst is headquartered in Coral Gables, FL., and was recognized on the Forbes 2024 list as one of America's most successful small-cap companies. For more information, please visit Catalyst's website at www.catalystpharma.com.
Forward-Looking Statements
This press release contains forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause Catalyst's actual results in future periods to differ materially from forecasted results. A number of factors, including those factors described in Catalyst's Annual Report on Form 10-K for the fiscal year 2023 and its other filings with the U.S. Securities and Exchange Commission ("SEC"), could adversely affect Catalyst. Copies of Catalyst's filings with the SEC are available from the SEC, may be found on Catalyst's website, or may be obtained upon request from Catalyst. Catalyst does not undertake any obligation to update the information contained herein, which speaks only as of this date.
Source: Catalyst Pharmaceuticals, Inc.
FAQ
How much did Catalyst Pharmaceuticals (CPRX) donate to Hurricane Helene relief efforts?
What is the purpose of Catalyst Pharmaceuticals' (CPRX) donation to the American Red Cross?
How many Red Cross disaster responders are working on Hurricane Helene relief efforts?
What services is the American Red Cross providing in response to Hurricane Helene?
